Wolfgang Renz

Wolfgang Renz is the founder of RedHill Biopharma Ltd. (founded in 2009).
He is currently an Independent Director at BetterLife Pharma, Inc. (since 2015), Director-Quebec Chapter at Canadian Liver Foundation (since 2009), and Chief Scientific Officer at Relevium Technologies, Inc. (since 2021).
Previously, he held positions such as Chief Executive Officer at Venn Life Sciences Holdings Plc (2008-2009), Chairman at German Center For Research & Innovation (2012-2015), Program Director at Aptalis Pharma Canada ULC (2004), Director-Clinical Operations at ICON Clinical Research (Canada), Inc. (2004-2006), VP-Business Model & Healthcare Innovation at Boehringer Ingelheim GmbH, Senior Vice President-Clinical Operations at inVentiv Health Clinical, Inc., Head-Global Strategic Business Unit at Merz Pharmaceuticals GmbH (2002-2003), Vice President-Global Business Development at Hesperion AG (2006-2007), President-International Business at Aptus Health, Inc., President at Samaritan Therapeutics (2008-2010), and General Manager at JSS Medical Research, Inc. (2009-2011).
He holds a doctorate degree from the University of Freiburg and the University of Freiburg Medical School (conferred in 1998).